Clinical Trials Update: Sept. 6, 2006
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
714498
Tropical Medicine in London, in research published online by The Lancet medical journal on Thursday. not new and had been made in many of the product-liability lawsuits filed against Philip Morris.
554707
NEWS: In 2002, weeks before President Bush announced a plan to protect African babies from AIDS, top US health officials were warned that research about the drug, nevirapine, was flawed
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
201618
The latest scientific news is about fighting aging, heart disease, and cancer.
612567
THURSDAY, Sept. 6 (HealthDay News) -- New studies from the first annual Breast Cancer Symposium shed light on racial differences in breast cancer, how not sticking with treatment can affect survival, and how nagging side effects cause people to stop their therapies.
402115
Two drugs provide good results in preliminary trials.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
442213
THURSDAY, Sept. 21 (HealthDay News) -- Some bad news has emerged from a study of an enzyme that is a major target in the effort to find new drugs to fight Alzheimer's disease.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
563594
The Kootenai Medical Center's North Idaho Cancer Center will begin offering some patients the option of taking part in trials of experimental cancer drugs, starting in January.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
92836
THURSDAY, Aug. 19 (HealthDayNews) -- A new screening technique to search for genes that change patients' response to cancer drugs and other medications has been developed by scientists at Washington University Medical Center.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.